Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells

Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth

(2011) Dennis W. Wolff et al.   INTERNATIONAL JOURNAL OF CANCER

Anticancer Effects of 15d-Prostaglandin-J2 in Wild-Type and Doxorubicin-Resistant Ovarian Cancer Cells: Novel Actions on SIRT1 and HDAC

(2011) Edwin de Jong et al.   PLoS One

A User's Guide to the Encyclopedia of DNA Elements (ENCODE)

(2011)   PLOS BIOLOGY

Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours

(2010) Helen J. Mackay et al.   EUROPEAN JOURNAL OF CANCER

Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells

(2010) Shelley B Hooks et al.   Molecular Cancer

G protein-coupled receptors: novel targets for drug discovery in cancer

(2010) Rosamaria Lappano et al.   NATURE REVIEWS DRUG DISCOVERY

Global Levels of Histone Modifications Predict Prognosis in Different Cancers

(2009) David B. Seligson et al.   AMERICAN JOURNAL OF PATHOLOGY

Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054

(2009) James W. Growcott   ANTI-CANCER DRUGS

Regulator of G-protein signaling (RGS) proteins in cancer biology

(2009) Jillian H. Hurst et al.   BIOCHEMICAL PHARMACOLOGY

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer

(2009) Meng Li et al.   BMC Medical Genomics

Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo

(2009) N Steele et al.   BRITISH JOURNAL OF CANCER

Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases

(2009) Shuying Liu et al.   CANCER CELL

Enhancing the apoptotic and therapeutic effects of HDAC inhibitors

(2009) Ailsa J. Frew et al.   CANCER LETTERS

Targeting Histone Deacetylases in Neuroblastoma

(2009) O. Witt et al.   CURRENT PHARMACEUTICAL DESIGN

RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling

(2009) Genqing Liang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice

(2009) H. Li et al.   MOLECULAR CANCER THERAPEUTICS

Lysophosphatidic Acid Stimulates Cell Growth by Different Mechanisms in SKOV-3 and Caov-3 Ovarian Cancer Cells: Distinct Roles for Gi- and Rho-Dependent Pathways

(2009) Jillian H. Hurst et al.   PHARMACOLOGY

Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer

(2009) Noriyuki Takai et al.   Journal of Oncology

Characterization of the transcriptional regulation of the regulator of G protein signaling 2 (RGS2) gene during 3T3-L1 preadipocyte differentiation

(2008) Ya-Shan Cheng et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues

(2008) Ke Long Jin et al.   Journal of Gynecologic Oncology

Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells

(2008) Michela Muscolini et al.   MOLECULAR CANCER THERAPEUTICS

Endogenous RGS proteins attenuate Gαi-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells

(2007) Jillian H. Hurst et al.   CELLULAR SIGNALLING